Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postoperative delirium after cardiac surgery in older adults
ACTRN12623001171606Phase 3Recruiting
- Sponsor
- University of Sydney
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Dexmedetomidine with Saline placebo (2 arms). Primary endpoint: Days alive and free of delirium and coma in the first 14 days post-operatively. Started Nov 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12623001171606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623001171606.